HSPA5 and renal cell carcinoma: The anticancer drugs 5-fluorouracil (5-FU) and doxorubicin become desensitized to renal cell carcinoma (RCC), due to the silencing of GRP78, by small interfering ribonucleic acid (siRNA) that induced G1 cell-cycle arrest and inhibited the growth of cells [184].